NCT06922162 Tickle Stimulation in Disorders of Consciousness (DoC)
| NCT ID | NCT06922162 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Anna Estraneo |
| Condition | Disorders of Consciousness |
| Study Type | OBSERVATIONAL |
| Enrollment | 45 participants |
| Start Date | 2023-06-30 |
| Primary Completion | 2025-07-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 45 participants in total. It began in 2023-06-30 with a primary completion date of 2025-07-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The aim of this project is to investigate whether tickling stimulations can have a short-term effect on the responsiveness of patients with Disorders of Consciousness due to Severe Acquired Brain Injury and to compare this effect with that of neutral tactile stimulations that do not induce tickling.
Eligibility Criteria
Inclusion Criteria: * Diagnosis of disorders of consciousness (DoC) based on the CRS-R scale; * Age ≥18 years; * Time since the event ≥ 28 days Exclusion Criteria: * Large craniectomy that may interfere with fNIRS recording; Unstable clinical conditions (e.g., respiratory failure, fever, status epilepticus, etc.); * Fractures, paralysis, injuries, or muscular dystrophy that prevent proper stimulation of the aforementioned body parts; * Lack of informed consent from the legal representative.
Contact & Investigator
Anna Estraneo, MD
PRINCIPAL INVESTIGATOR
Fondazione Don Gnocchi
Frequently Asked Questions
Who can join the NCT06922162 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Disorders of Consciousness. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06922162 currently recruiting?
Yes, NCT06922162 is actively recruiting participants. Contact the research team at sabagnale@dongnocchi.it for enrollment information.
Where is the NCT06922162 trial being conducted?
This trial is being conducted at Liège, Belgium, Sant'Angelo dei Lombardi, Italy.
Who is sponsoring the NCT06922162 clinical trial?
NCT06922162 is sponsored by Anna Estraneo. The principal investigator is Anna Estraneo, MD at Fondazione Don Gnocchi. The trial plans to enroll 45 participants.